Professor Angus Dalgleish, a British oncologist and cancer immunologist, says observations from his clinical practice and several published studies have raised concerns about how repeated Covid booster vaccinations may affect some cancer patients. The discussion, featured on The Jimmy Dore Show, examines published research alongside broader criticism of the pandemic response.
INR Report: Based on reporting by The Jimmy Dore Show HERE.
Editorial note: The interview contains claims about Covid-19 vaccines, cancer incidence and government actions that remain the subject of ongoing scientific debate. The discussion presented reflects the views of the interview participants and references studies they cite. Readers are encouraged to consider the full body of peer-reviewed evidence and guidance from health authorities alongside these claims.
Oncologist Describes Clinical Observations
Professor Angus Dalgleish, founding Chair of Oncology at St George's, University of London, said he first became concerned after observing a number of cancer patients whose previously stable disease appeared to recur following Covid booster vaccinations.
According to Dalgleish, several patients with melanoma experienced relapses after receiving booster doses. He said this prompted him to investigate whether published research offered a possible explanation.
Dalgleish referred to a study from researchers in Madrid which he said reported evidence of T-cell exhaustion following a third Covid vaccination in cancer patients, suggesting this immune response may warrant further investigation in relation to cancers that rely on immune surveillance.
Population Studies Discussed
During the interview, Dalgleish said he considers epidemiological studies to provide some of the strongest evidence requiring further scientific examination.
Among the studies discussed were:
- A Japanese study analysing cancer incidence trends.
- A South Korean population study involving more than 8 million people.
- Data from the United States examining cancer mortality and incidence following vaccine rollout.
Dalgleish argued these studies indicate increases in several forms of cancer following vaccination and said the findings deserve continued scientific scrutiny.
Questions About Immune Function
The discussion centred on whether repeated Covid booster doses could affect immune function in ways that may influence cancer development or recurrence.
Dalgleish argued that suppression or exhaustion of specific T-cell responses could reduce the body's ability to detect and control certain cancers.
He stressed that these observations require ongoing investigation but said they are consistent with findings reported in several published papers referenced during the interview.
Wider Scientific Debate
Host Jimmy Dore also interviewed researcher Nicholas Hulscher from the McCullough Foundation.
Hulscher argued that multiple published studies report mechanisms through which mRNA vaccines may influence cancer biology, including effects on immune regulation and inflammatory pathways.
He also discussed studies examining residual DNA fragments, including SV40 promoter sequences, identified in analyses of some vaccine samples, arguing these findings require further research and regulatory attention.
The interview presents these topics as evidence supporting further investigation into long-term vaccine safety.
Manufacturing And DNA Questions
A significant portion of the discussion focused on concerns surrounding the manufacturing process used for mRNA vaccines.
Researcher Nicholas Hulscher argued that residual DNA plasmids, including sequences associated with SV40 promoter elements, have been identified in laboratory analyses of some vaccine samples.
According to Hulscher, these findings raise questions about whether residual genetic material could contribute to biological effects beyond those originally anticipated.
He referred to peer-reviewed studies which he said warrant further scientific investigation into genomic integration and other possible long-term biological mechanisms.
Calls For Greater Transparency
Both Dalgleish and Hulscher argued that scientists should be free to investigate potential long-term adverse effects without fear of professional repercussions.
The interview criticised what the speakers described as resistance within parts of the scientific and medical establishment to openly debate emerging evidence relating to Covid vaccines.
They maintained that ongoing research should continue wherever credible questions remain unanswered.
Debate Over Scientific Consensus
The discussion also examined how disagreements over pandemic policy continue to influence public confidence in medical institutions.
Jimmy Dore argued that several public health measures adopted during the pandemic—including lockdowns, school closures and expectations surrounding vaccine effectiveness—have since been challenged by later evidence and scientific debate.
The interview suggested that this history has contributed to greater public scepticism when new safety concerns are raised.
Participants argued that scientific conclusions should continue to evolve as additional evidence becomes available.
Does This Affect New Zealand?
Cancer remains one of New Zealand's leading causes of death, with health data showing a growing number of cancer diagnoses and deaths as the population ages. Concerns about younger cancer patients have also received increasing public attention.
The claims discussed in this interview are likely to be of interest to New Zealand readers because they relate to vaccine safety, cancer incidence and long-term public health policy.
While the interview participants argue that emerging studies justify further investigation into possible links between Covid vaccination and certain cancers, these conclusions remain disputed within the wider scientific community. Major health authorities continue to recommend Covid vaccination for eligible groups while ongoing research examines long-term safety outcomes.
As additional evidence emerges, the scientific understanding of these questions may continue to develop.
Source
Original Reporting: The Jimmy Dore Show
Publication: The Jimmy Dore Show
Independent reporting. Original context. Credited sources.